0001209191-22-018438.txt : 20220314
0001209191-22-018438.hdr.sgml : 20220314
20220314160749
ACCESSION NUMBER: 0001209191-22-018438
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220310
FILED AS OF DATE: 20220314
DATE AS OF CHANGE: 20220314
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Halstead Michael
CENTRAL INDEX KEY: 0001521548
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36274
FILM NUMBER: 22736607
MAIL ADDRESS:
STREET 1: C/O WARNER CHILCOTT CORPORATION
STREET 2: 100 ENTERPRISE DRIVE
CITY: ROCKAWAY
STATE: NJ
ZIP: 07866
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intra-Cellular Therapies, Inc.
CENTRAL INDEX KEY: 0001567514
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 364742850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 430 EAST 29TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 212-923-3344
MAIL ADDRESS:
STREET 1: 430 EAST 29TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10016
FORMER COMPANY:
FORMER CONFORMED NAME: Oneida Resources Corp.
DATE OF NAME CHANGE: 20130122
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-10
0
0001567514
Intra-Cellular Therapies, Inc.
ITCI
0001521548
Halstead Michael
C/O INTRA-CELLULAR THERAPIES, INC.
430 EAST 29TH STREET
NEW YORK
NY
10016
0
1
0
0
EVP and General Counsel
Stock Option (right to buy)
56.73
2022-03-10
4
A
0
17916
0.00
A
2032-03-09
Common Stock
17916
17916
D
Restricted Stock Units
2022-03-10
4
A
0
22034
0.00
A
Common Stock
22034
22034
D
On March 10, 2022, the reporting person was granted options to purchase 17,916 shares of common stock, vesting in three equal annual installments beginning on the first anniversary of the grant date.
Each restricted stock unit represents a contingent right to receive one share of common stock.
On March 10, 2022, the reporting person was granted 22,034 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
/s/ Lawrence J. Hineline, Attorney-in-fact
2022-03-14